Some enzymes associated with LDL and HDL have been proposed as putative ischemic stroke biomarkers, mainly, including platelet-activating factor acetylhydrolases (PAF-AH), also known as lipoprotein-associated phospholipase A2, and paraoxonase-1 (PON1). The gene discussed is PLA2G7; the disease is ischemic stroke.